Nowadays there is a special focus on immunotherapeutic treatment, including in solid tumors (such as melanoma, lung tumors, lymphoma), given the recent success achieved, particularly using PD-L1 blockade to enhance anti-tumor immune responses [6,7]. Here, CD274 is linked to neoplasm.